Literature DB >> 30520866

Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?

Mateo Aboy1, Cristina Crespo1, Kathleen Liddell1, Johnathon Liddicoat1, Matthew Jordan1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30520866     DOI： 10.1038/nbt.4308

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  7 in total

1.  Patent law--patent on life form--man-made modification of microorganism is patentable subject matter under 35 U.S.C. 101--Diamond v. Chakrabarty, 100 S.Ct. 2204 (1980)

Authors:  Scott Vidas
Journal:  Hamline Law Rev       Date:  1981-01

Review 2.  The History of Patenting Genetic Material.

Authors:  Jacob S Sherkow; Henry T Greely
Journal:  Annu Rev Genet       Date:  2015-10-06       Impact factor: 16.830

3.  AMP v. Myriad: a surgical strike on Blockbuster business models.

Authors:  Richard E Gold; Robert Cook-Deegan; Tania Bubela
Journal:  Sci Transl Med       Date:  2013-07-03       Impact factor: 17.956

4.  The changing life science patent landscape.

Authors:  Arti K Rai; Jacob S Sherkow
Journal:  Nat Biotechnol       Date:  2016-03       Impact factor: 54.908

5.  Myriad's impact on gene patents.

Authors:  Mateo Aboy; Kathleen Liddell; Johnathon Liddicoat; Cristina Crespo
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

6.  After Myriad, what makes a gene patent claim 'markedly different' from nature?

Authors:  Mateo Aboy; Johnathon Liddicoat; Kathleen Liddell; Matthew Jordan; Cristina Crespo
Journal:  Nat Biotechnol       Date:  2017-09-11       Impact factor: 54.908

7.  Genetics. Moving beyond "isolated" gene patents.

Authors:  Arti K Rai; Robert Cook-Deegan
Journal:  Science       Date:  2013-06-27       Impact factor: 47.728
  7 in total
  1 in total

1.  European patent protection for medical uses of known products and drug repurposing.

Authors:  Mateo Aboy; Kathleen Liddell; Matthew Jordan; Cristina Crespo; Johnathon Liddicoat
Journal:  Nat Biotechnol       Date:  2022-04       Impact factor: 54.908
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.